Bottom line
- Total investment $752K – $1.5M including a $65K franchise fee.
- No Item 19 financial performance data disclosed — the franchisor chose not to publish revenue figures.
- Rated STRONG with a risk score of 52/100. SBA loan default rate of 0.0% across 10 loans (below the industry average).
- Auditor disclosed a going-concern note — flagged doubt about the franchisor's ability to continue operations. Verify against the latest FDD.
Item 1 · who you're contracting with
The Franchisor
Yale framework · single-unit ROIC
Returns Analysis
Pulls Item 7 (investment) and Item 19 (revenue) from this brand's FDD into the Yale unlevered-ROIC formula. Override any input to stress-test it against your own assumptions.
The model · Yale framework
What would one Upgrade Labs unit return on the cash you put in?
Unlevered ROIC · per unit
14%
Below typical band (30–60%)
Overview
About
Upgrade Labs operates premium biohacking and longevity wellness facilities offering cryotherapy, hyperbaric oxygen, IV therapy, and other performance-enhancement services. Franchisees manage day-to-day operations of high-touch, membership-based wellness centers targeting affluent health-conscious consumers, handling member acquisition, retention, clinical staff oversight, and equipment maintenance.
Item 7 · what it costs
The Vitals
Item 19
Financial Performance
This franchisor did not disclose financial performance representations in Item 19, or our extractor could not parse them.
Item 20 · unit dynamics
The Growth Chart
Year-over-year franchised unit counts and net change. Source: FDD Item 20.
Item 20 · 14 states with active franchisees
The Territory Map
Derived from franchisee contact records. Shows states with at least one current operator — not where the franchisor is registered to sell new units (that data is re-extracting in a future refresh).
States derived from franchisee phone area codes (Item 20). Approximate — ported numbers may show the original state, not the franchisee's current location.
Government records
SBA Loan Data
Aggregated from SBA 7(a) loan disclosures, public data unique to FranchiseVerdict.
FranchiseVerdict rating + FDD Items 3, 5, 6, 12, 17
Risk & Legal
Early-stage biotech/wellness franchise with minimal unit history, undisclosed financials, and high capital requirements presents elevated risk despite no litigation or going concern issues.
Score breakdown · what drove the 52 / 100 rating
- 01MINORNo Item 19 financial performance representation — cannot verify average unit economics or validate claimed 150% YoY growth credibility
- 02MINOROnly 7 units in system creates extreme difficulty validating unit profitability, territory viability, and operational scalability
- 03MINORHigh initial investment ($751.5K–$1.5M+) paired with non-transparent revenue/profit metrics creates significant financial risk for franchisees
- 04MINORAggressive 150% YoY growth rate (7 units) is statistically unreliable — could indicate unsustainable expansion or selective reporting
- 05MINORDual royalty structure (greater of $2,500 or 7.5%) may create cash flow stress for locations struggling to reach $33,333 monthly gross sales
Severity inferred from the FDD text · not a regulatory classification
FDD Items 5, 6, 12, 17 · continued from Risk & Legal
Contract & Territory Detail
Item 11
Training & Operations
Item 20
Franchisee Contacts
Phone numbers extracted directly from this brand's FDD Item 20. After purchase, you'll also receive a list of validation questions tailored to this brand.
Franchisee contacts
16 numbers
One-time purchase · CSV download · Validation questions included
FDD download
Upgrade Labs · FDD (2025) PDF